These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20845417)

  • 1. Efficient multicomponent reaction synthesis of the schistosomiasis drug praziquantel.
    Cao H; Liu H; Dömling A
    Chemistry; 2010 Nov; 16(41):12296-8. PubMed ID: 20845417
    [No Abstract]   [Full Text] [Related]  

  • 2. Praziquantel derivatives exhibit activity against both juvenile and adult Schistosoma japonicum.
    Duan WW; Qiu SJ; Zhao Y; Sun H; Qiao C; Xia CM
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1587-90. PubMed ID: 22264473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of new praziquantel analogues: potential candidates for the treatment of schistosomiasis.
    Sadhu PS; Kumar SN; Chandrasekharam M; Pica-Mattoccia L; Cioli D; Rao VJ
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1103-6. PubMed ID: 22217873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Praziquantel.
    Cioli D; Pica-Mattoccia L
    Parasitol Res; 2003 Jun; 90 Supp 1():S3-9. PubMed ID: 12811543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antischistosomal activity of a new 2-nicotinoyl dipeptide analogue of praziquantel.
    Abo-Ghalia MH; Soliman AE
    Arzneimittelforschung; 1996 Feb; 46(2):207-9. PubMed ID: 8720316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferrocenyl derivatives of the anthelmintic praziquantel: design, synthesis, and biological evaluation.
    Patra M; Ingram K; Pierroz V; Ferrari S; Spingler B; Keiser J; Gasser G
    J Med Chem; 2012 Oct; 55(20):8790-8. PubMed ID: 23005702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a new antischistosomally active and toxicologically tolerant C-12 monothione surrogate of the universal antihelmintic praziquantel.
    Abo-Ghalia MH; Soliman AM
    Acta Pol Pharm; 2002; 59(4):313-20. PubMed ID: 12403307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
    Liu LX; Li-Li J; Qiong C; Xiao-Lin F
    Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and study of the antischistosomal potency and induced biological parameters of a new 2-palmitoyl analogue of the universal antihelminthic praziquantel.
    Abo-Ghalia MH; Soliman AM
    Acta Pol Pharm; 2000; 57(1):53-9. PubMed ID: 10846798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [(η(6)-Praziquantel)Cr(CO)3] derivatives with remarkable in vitro anti-schistosomal activity.
    Patra M; Ingram K; Pierroz V; Ferrari S; Spingler B; Gasser RB; Keiser J; Gasser G
    Chemistry; 2013 Feb; 19(7):2232-5. PubMed ID: 23296750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and SAR studies of praziquantel derivatives with activity against Schistosoma japonicum.
    Wang WL; Song LJ; Chen X; Yin XR; Fan WH; Wang GP; Yu CX; Feng B
    Molecules; 2013 Jul; 18(8):9163-78. PubMed ID: 23912271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward organometallic antischistosomal drug candidates.
    Hess J; Keiser J; Gasser G
    Future Med Chem; 2015; 7(6):821-30. PubMed ID: 25996072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schistosomiasis control: praziquantel forever?
    Cioli D; Pica-Mattoccia L; Basso A; Guidi A
    Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Coadministration of pyquiton and furapromidum in the treatment of experimental schistosomiasis japonica (author's transl)].
    Shao BR; Xiao SH; Zhan CQ; Xu YQ; Pan QR
    Yao Xue Xue Bao; 1981 Feb; 16(2):149-52. PubMed ID: 7304183
    [No Abstract]   [Full Text] [Related]  

  • 15. Macromolecular bases of antischistosomal therapy.
    Angelucci F; Miele AE; Boumis G; Brunori M; Dimastrogiovanni D; Bellelli A
    Curr Top Med Chem; 2011; 11(16):2012-28. PubMed ID: 21619508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Praziquantel and schistosomiasis.
    Dömling A; Khoury K
    ChemMedChem; 2010 Sep; 5(9):1420-34. PubMed ID: 20677314
    [No Abstract]   [Full Text] [Related]  

  • 17. Schistosomiasis control: keep taking the tablets.
    Hagan P; Appleton CC; Coles GC; Kusel JR; Tchuem-Tchuenté LA
    Trends Parasitol; 2004 Feb; 20(2):92-7. PubMed ID: 14747023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could we expect new praziquantel derivatives? A meta pharmacometrics/pharmacoinformatics analysis of all antischistosomal praziquantel derivatives found in the literature.
    da Silva VBR; Boucherle B; El-Methni J; Hoffmann B; da Silva AL; Fortune A; de Lima MDCA; Thomas A
    SAR QSAR Environ Res; 2019 Jun; 30(6):383-401. PubMed ID: 31144535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Observations on the histopathological changes of Schistosoma japonicum and host liver caused by pyquiton in experimental chemotherapy (author's transl)].
    Yang YQ; Yang HZ; Xiao SH; Shao BR; Tang XM; Zhu ZG; Zhang HX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1979 Sep; 1(1):7-12. PubMed ID: 262815
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study progress on the mode of action of praziquantel against schistosomes].
    Xiao SH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Dec; 25(6):492-502. PubMed ID: 18441900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.